Analyst Alex Carchidi returns to update investors on the psychedelics industry. This is the full conversation of an interview originally published on Investing Experts.

• (2:50) Industry's collapse and consolidation
• (5:00) Compass Pathways timeline for clinical trials
• (15:00) Super-risky biotech companies low on cash - don't bet on just 1 company
• (21:20) Atai and Cybin's recent wins
• (32:55) Ketamine clinics and viable business models

Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Cybin: A Leading Early-Stage Psychedelics Play
Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics

Podcast transcripts on Seeking Alpha

Cannabis Investing Podcast Twitter